You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Telitacicept

Showing 1 - 22 of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nephrotic Syndrome in Children, Telitacicept Trial in Hangzhou (Telitacicept)

Recruiting
  • Nephrotic Syndrome in Children
  • Telitacicept
  • Telitacicept
  • Hangzhou, Zhejiang, China
    Children's Hospital, Zhejiang University School of Medicine
Nov 8, 2023

Telitacicept on Transitional Regulatory B Cells in Systemic

Recruiting
  • Telitacicept
  • +2 more
    • Jinan, Shandong, China
      Yanfeng Hou
    Nov 19, 2023

    ANCA Associated Vasculitis Trial in Beijing (Telitacicept, Placebo of Telitacicept)

    Recruiting
    • ANCA Associated Vasculitis
    • Telitacicept
    • Placebo of Telitacicept
    • Beijing, China
      Peking Union Medical College Hospital
    Jul 19, 2023

    Systemic Lupus Erythematosus Trial (Telitacicept, conventional therapy, Placebo)

    Not yet recruiting
    • Systemic Lupus Erythematosus
    • Telitacicept
    • +2 more
    • (no location specified)
    Jun 26, 2023

    ANCA-associated Vasculitis, Maintenance Therapy Trial in Beijing (Azathioprine, Telitacicept)

    Recruiting
    • ANCA-associated Vasculitis
    • Maintenance Therapy
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jul 20, 2023

    IgA Nephropathy Trial in Hangzhou (Telitacicept, Placebo)

    Not yet recruiting
    • IgA Nephropathy
    • Telitacicept
    • Placebo
    • Hangzhou, Zhejiang, China
      The Second Affiliated Hospital of Zhejiang University School of
    Oct 25, 2022

    APS Secondary to SLE

    Recruiting
    • Antiphospholipid Syndrome
    • Telitacicept
    • +5 more
    • Jinan, Shandong, China
      Qilu Hospital
    Nov 30, 2022

    Telitacicept and Belimumab in Active Lupus Nephritis in Real

    Not yet recruiting
    • Lupus Nephritis
    • +2 more
    • (no location specified)
    Oct 18, 2022

    Systemic Lupus Erythematosus Trial (Telitacicept, Hydroxychloroquine, Prednisone)

    Not yet recruiting
    • Systemic Lupus Erythematosus
    • Telitacicept
    • +6 more
    • (no location specified)
    Dec 28, 2022

    Lupus Erythematosus, Systemic Trial in China (Telitacicept, Standard of Care)

    Recruiting
    • Lupus Erythematosus, Systemic
    • Telitacicept
    • Standard of Care
    • Beijing, Beijing, China
    • +19 more
    Jun 1, 2023

    Systemic Lupus Erythematosus Trial in Beijing (Telitacicept, Interleukin-2)

    Recruiting
    • Systemic Lupus Erythematosus
    • Beijing, Beijing, China
      Department of Rheumatology and Immunology, Peking University Peo
    Apr 26, 2022

    Systemic Lupus Erythematosus Trial in China (Telitacicept 2.5 mg/kg)

    Not yet recruiting
    • Systemic Lupus Erythematosus
    • Telitacicept 2.5 mg/kg
    • Beijing, Beijing, China
    • +11 more
    Jan 8, 2023

    Anti Phospholipid Syndrome Trial in Beijing (Telitacicept)

    Recruiting
    • Anti Phospholipid Syndrome
    • Telitacicept
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Oct 12, 2021

    IgA Nephropathy Trial in United States (Telitacicept 160mg, Telitacicept 240mg, Placebo)

    Recruiting
    • IgA Nephropathy
    • Telitacicept 160mg
    • +2 more
    • Los Angeles, California
    • +15 more
    Feb 7, 2022

    Lupus Nephritis Trial in China (Telitacicept 240 mg, Telitacicept 160 mg, Placebo)

    Not yet recruiting
    • Lupus Nephritis
    • Telitacicept 240 mg
    • +2 more
    • Hefei, Anhui, China
    • +44 more
    Jan 11, 2023

    Systemic Lupus Erythematosus Trial in China (Telitacicept, standard therapy)

    Recruiting
    • Systemic Lupus Erythematosus
    • Telitacicept
    • standard therapy
    • Bengbu, Anhui, China
    • +18 more
    May 22, 2022

    Multiple Sclerosis, Relapsing-Remitting Trial in Guangzhou (RC18 160mg, RC18 240mg)

    Recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • RC18 160mg
    • RC18 240mg
    • Guangzhou, Guangdong, China
      the Third Affiliated Hospital,Sun Yat-Sen University
    Jan 7, 2022

    Connective Tissue Diseases, Thrombocytopenia Trial in China (Telitacicept, Placebo)

    Not yet recruiting
    • Connective Tissue Diseases
    • Thrombocytopenia
    • Telitacicept
    • Placebo
    • Hefei, Anhui, China
    • +21 more
    Aug 18, 2023

    Myasthenia Gravis, Generalized Trial in China (Telitacicept, Placebo)

    Not yet recruiting
    • Myasthenia Gravis, Generalized
    • Telitacicept
    • Placebo
    • Bengbu, Anhui, China
    • +50 more
    Feb 12, 2023

    Primary Sjogren's Syndrome Trial in China (Telitacicept 80 mg, Telitacicept 160 mg, Placebo)

    Not yet recruiting
    • Primary Sjogren's Syndrome
    • Telitacicept 80 mg
    • +2 more
    • Bengbu, Anhui, China
    • +67 more
    Jan 5, 2023

    IgA Nephropathy Trial in China (Telitacicept, Placebo)

    Not yet recruiting
    • IgA Nephropathy
    • Telitacicept
    • Placebo
    • Hefei, Anhui, China
    • +79 more
    Mar 22, 2023

    Moderate and Severe RheumatoId Arthritis Trial in Beijing (Placebo plus MTX, RC18 160 mg plus MTX)

    Active, not recruiting
    • Moderate and Severe RheumatoId Arthritis
    • Placebo plus MTX
    • RC18 160 mg plus MTX
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jan 9, 2022